Kisqali 600 MG daily dose 63S
Ended Awarded
- Contract number
- SPE2DB25FZ0WJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $76,497
Award facts
- Contract value 100% obligated
- $76,496.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for supply of Kisqali 600 mg daily dose tablets (63-count) with a firm fixed price ceiling value of $76,496.76. This competitive, non-set-aside award is scheduled for completion by September 12, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that supports pharmaceutical supply needs across the Defense Health System.
Kisqali is a hormone receptor-positive breast cancer treatment, reflecting the critical role AmerisourceBergen plays in supplying specialized pharmaceutical products to military and veteran healthcare systems. As a major pharmaceutical distributor and SAM.gov-registered vendor, AmerisourceBergen maintains an extensive portfolio of federal contract awards covering diverse therapeutic domains including oncology medications, vaccines, and medical supplies. This delivery order exemplifies the company's capability to fulfill federal medical procurement requirements through the DLA's comprehensive global pharmaceutical support vehicle, which enables flexible sourcing of brand-name and generic medications to support military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DB25FZ0WJ?
SPE2DB25FZ0WJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FZ0WJ worth?
The government has obligated $76,497 on SPE2DB25FZ0WJ.
Is contract SPE2DB25FZ0WJ an order under another contract?
Yes. SPE2DB25FZ0WJ is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FZ0WJ competed?
The extent of competition for SPE2DB25FZ0WJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award